Skip to main content

Table 1 Antiphospholipid antibodies and other serological data of our patient

From: Gastrointestinal symptoms as the first manifestation of antiphospholipid syndrome

Antiphospholipid antibody

Titer

Anticardiolipin-IgG (U/mL) (< 12.0 U/mL)

20

Anticardiolipin-IgM (U/mL) (< 12.0 U/mL)

70

Anti-β2 glycoprotein (U/mL) (< 20.0 U/mL)

143

Lupus anticoagulant-dRVVT (ratio) (< 1.2)

1.49

Anti-SSA-52/Ro52

Positive

Anti-double-stranded DNA antibody (IIF)

Positive (1:320)

  1. Characteristics of high-risk APL (1) ≥ 2 intervals of 12 weeks, presence of lupus anticoagulants (as determined by ISTH guidelines), (2) or the presence of any two or three aPL positive lupus anticoagulants, ACL, or anti-β2GPI, (3) or persistent high titer of APL
  2. IgG immunoglobulin G, IgM immunoglobulin M, dRVVT dilute Russell viper venom time, IIF indirect immunofluorescence